Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.

Expresses the sense of Congress that:

the efficient administration of Medicare and Medicaid encompasses federal efforts to achieve good value for funds spent in those programs; the Centers for Medicare & Medicaid Services (CMS) has the authority to require direct-to-consumer television advertisements of prescription drugs and biological products to include the drug or product's list price; and the proposed rule by the CMS published in the Federal Register on October 18, 2018, when finalized, shall be codified without change.